First-ever transmitted Alzheimer’s cases reported in new study
Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease. They didn’t even have the known genetic mutations that can set people on the course for such early-onset Alzheimer’s. advertisement But this small handful of patients did share a particular history. As children, they had received growth hormone taken from the brains of human cadavers, which used to be a treatment for a number of conditions that caused short stature. Now, decades later, they were showing signs of Alzheimer’s. In the interim, scientists had discovered that that type of hormone treatment they got could unwittingly transfer bits of protein into recipients’ brains. In some cases, it had induced a fatal brain disease called Creutzfeldt-Jakob disease, or CJD — a finding that led to the banning of the procedure 40 years ago. It seemed that it was
L ONDON — There was something odd about these Alzheimer’s cases. Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease. They didn’t even have the known genetic mutations that can set people on the course for such early-onset Alzheimer’s. Advertisement But this small handful of patients did share a particular history. As children, they had received growth hormone taken from the brains of human cadavers, which used to
Explore this link on the map →related reading
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Research Areas - Svendsen Lab | Cedars-Sinaicedars-sinai.edu
- ALS - Wikipediaen.wikipedia.org
- Was a Mushroom Behind an ALS Outbreak in the Alps? - The Atlantictheatlantic.com
- Bottlenecks of Aging - Amaranth Foundationamaranth.foundation
- It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough | Jonathan Schott | The Guardiantheguardian.com
- Amyloidosis - Symptoms, Causes, Treatment | NORDrarediseases.org
- Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Programirp.nih.gov
- Contrary Research on X: "The Virtual Cell Revolution" / Xx.com
- Your Review: Of Mice, Mechanisms, and Dementiaastralcodexten.com
- AI for Alzheimer’sopenaifoundation.org
- Notionnotion.so